Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.

Eur Radiol · 2017 · PMC5674123 · PMID 28656463

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

did not reach statistical significancep = 0.12not close (p > 0.1)

For the remaining patient (1/14) with four FLs the change in sFF did not reach statistical significance (median sFF 0.27 and 0.36 a.u. at baseline and post-2nd cycle respectively, p = 0.12).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.